Published in J Clin Invest on August 01, 2004
Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology (2014) 2.20
Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest (2009) 2.08
α-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology (2010) 1.82
Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology (2007) 1.81
Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (2013) 1.80
Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia. Sci Transl Med (2011) 1.79
The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis (2007) 1.74
DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia. Hepatology (2011) 1.67
Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology (2007) 1.62
Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol (2005) 1.51
Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology (2006) 1.44
Effect of rotavirus strain on the murine model of biliary atresia. J Virol (2006) 1.31
Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J Virol (2008) 1.28
Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med (2011) 1.23
MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia. J Pediatr Gastroenterol Nutr (2012) 1.18
Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis (2013) 1.18
Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet (2010) 1.17
Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier. PLoS One (2011) 1.17
Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology (2012) 1.16
Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia. J Hepatol (2010) 1.14
Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia. Hepatology (2012) 1.14
Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest (2011) 1.13
Rotavirus and reovirus modulation of the interferon response. J Interferon Cytokine Res (2009) 1.11
Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int (2008) 1.11
Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol (2008) 1.07
Cholangiocyte secretion of chemokines in experimental biliary atresia. J Pediatr Surg (2009) 1.03
Clues to the etiology of bile duct injury in biliary atresia. Semin Liver Dis (2013) 1.00
Macrophages are targeted by rotavirus in experimental biliary atresia and induce neutrophil chemotaxis by Mip2/Cxcl2. Pediatr Res (2010) 1.00
Staging of biliary atresia at diagnosis by molecular profiling of the liver. Genome Med (2010) 0.99
Recent advances in the pathogenesis and management of biliary atresia. Curr Opin Pediatr (2015) 0.94
Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol (2006) 0.94
Gene expression profile of the infective murine model for biliary atresia. Pediatr Surg Int (2006) 0.94
Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol (2006) 0.94
Replication of a GWAS signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia. Hum Genet (2013) 0.92
Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol (2007) 0.91
Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia. Hepatology (2014) 0.91
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor. BMC Gastroenterol (2006) 0.91
Experimental obstructive cholestasis: the wound-like inflammatory liver response. Fibrogenesis Tissue Repair (2008) 0.91
Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model. Immunology (2010) 0.89
Rotavirus replication in the cholangiocyte mediates the temporal dependence of murine biliary atresia. PLoS One (2013) 0.88
Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia. J Hepatol (2013) 0.88
HMGB1-promoted and TLR2/4-dependent NK cell maturation and activation take part in rotavirus-induced murine biliary atresia. PLoS Pathog (2014) 0.88
Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia. Virology (2011) 0.86
Rotavirus infection of human cholangiocytes parallels the murine model of biliary atresia. J Surg Res (2012) 0.86
Identification of intramural epithelial networks linked to peribiliary glands that express progenitor cell markers and proliferate after injury in mice. Hepatology (2013) 0.85
Extrahepatic cholangiocyte cilia are abnormal in biliary atresia. J Pediatr Gastroenterol Nutr (2013) 0.85
Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia. BMC Syst Biol (2013) 0.83
Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia. J Surg Res (2009) 0.83
B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia. PLoS One (2013) 0.82
Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis. Front Biosci (Landmark Ed) (2009) 0.81
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol (2015) 0.80
Biliary atresia: interdisciplinary initiatives focus on a rare disease. Pediatr Surg Int (2007) 0.80
Association of interferon-gamma gene polymorphisms in Taiwanese children with biliary atresia. J Clin Immunol (2009) 0.80
What Causes Biliary Atresia? Unique Aspects of the Neonatal Immune System Provide Clues to Disease Pathogenesis. Cell Mol Gastroenterol Hepatol (2015) 0.79
Interferon-gamma directly mediates developmental biliary defects. Zebrafish (2013) 0.78
Biliary atresia: Where do we stand now? World J Hepatol (2016) 0.77
Natural killer cells promote long-term hepatobiliary inflammation in a low-dose rotavirus model of experimental biliary atresia. PLoS One (2015) 0.77
The Sea Lamprey as an Etiological Model for Biliary Atresia. Biomed Res Int (2015) 0.77
Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia. PLoS One (2016) 0.77
Silencing of the rotavirus NSP4 protein decreases the incidence of biliary atresia in murine model. PLoS One (2011) 0.77
Role of myeloid differentiation factor 88 in Rhesus rotavirus-induced biliary atresia. J Surg Res (2013) 0.77
Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles. Vaccine (2013) 0.76
Rhesus rotavirus VP4 sequence-specific activation of mononuclear cells is associated with cholangiopathy in murine biliary atresia. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
High-dose IgG therapy mitigates bile duct-targeted inflammation and obstruction in a mouse model of biliary atresia. Pediatr Res (2014) 0.76
Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets (2015) 0.76
Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells. Development (2017) 0.75
Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway. Cell Death Differ (2017) 0.75
Preferential TNFα signaling via TNFR2 regulates epithelial injury and duct obstruction in experimental biliary atresia. JCI Insight (2017) 0.75
The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia. Hepatology (2016) 0.75
The SRL peptide of Rhesus Rotavirus VP4 protein governs cholangiocyte infection and the murine model of biliary atresia. Hepatology (2016) 0.75
Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia. PLoS One (2017) 0.75
MicroRNA-155 modulates bile duct inflammation via targeting suppressor of cytokine signaling 1 in biliary atresia. Pediatr Res (2017) 0.75
Update on investigations pertaining to the pathogenesis of biliary atresia. Pediatr Surg Int (2017) 0.75
A point mutation in the Rhesus rotavirus VP4 protein generated through rotavirus reverse genetics system attenuates the murine model of biliary atresia. J Virol (2017) 0.75
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med (1998) 4.52
Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol (1999) 2.61
Reversal of left-right asymmetry: a situs inversus mutation. Science (1993) 2.56
Cytokines and autoimmunity. Nat Rev Immunol (2002) 2.51
Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet (2002) 2.44
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet (2000) 1.92
Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest (1997) 1.89
The cytochemical localization of esterase. J Natl Cancer Inst (1957) 1.87
Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology (1996) 1.83
Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr (2003) 1.80
Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology (1996) 1.78
New aspects in a murine model for extrahepatic biliary atresia. J Pediatr Surg (1997) 1.66
Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol (2002) 1.56
Etiopathogenesis of biliary atresia. Semin Liver Dis (2001) 1.52
Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest (2003) 1.48
Heterogeneity in the structural glycoprotein (VP7) of simian rotavirus SA11. Virology (1982) 1.47
Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol (2001) 1.37
Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest (1980) 1.35
Immunological gap in the infectious animal model for biliary atresia. J Surg Res (2001) 1.33
IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice. J Immunol (1995) 1.17
IP-10 and Mig facilitate accumulation of T cells in the virus-infected liver. Cell Immunol (2002) 1.13
Extrahepatic biliary atresia: a disease or a phenotype? Hepatology (2002) 1.12
Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol (2001) 1.07
Differential effects of endogenous and exogenous interferon-gamma on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol (1998) 1.03
Anomalous development of the hepatobiliary system in the Inv mouse. Hepatology (1999) 1.02
Progress in developing animal models for biliary atresia. Eur J Pediatr Surg (1998) 1.01
Duct formation by immortalized mouse cholangiocytes: an in vitro model for cholangiopathies. Lab Invest (1998) 1.00
Treatment of extrahepatic biliary atresia with interferon-alpha in a murine infectious model. Pediatr Res (1997) 0.99
Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum Genet (2001) 0.97
The role of reovirus type 3 infection in an established murine model for biliary atresia. Eur J Pediatr Surg (2002) 0.92
IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol (1994) 0.92
Experimental reovirus type 3-induced murine biliary tract disease. J Pediatr Surg (1992) 0.92
Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice. Hepatology (1999) 0.89
Immunity to homologous rotavirus infection in adult mice: response. Trends Microbiol (2000) 0.79
Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol (2004) 3.15
Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet (2002) 2.44
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest (2014) 2.31
Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology (2004) 2.28
Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology (2014) 2.20
Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest (2009) 2.08
Independent and overlapping transcriptional activation during liver development and regeneration in mice. Hepatology (2002) 2.02
Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology (2007) 1.81
Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology (2013) 1.80
Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia. Sci Transl Med (2011) 1.79
The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68
Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology (2007) 1.68
Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology (2007) 1.62
Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis (2005) 1.52
IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism. Hepatology (2015) 1.52
Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaques. Infect Immun (2003) 1.50
Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. J Pediatr Surg (2009) 1.42
Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol (2009) 1.37
Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis. Gastroenterology (2006) 1.35
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol (2002) 1.32
Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J (2002) 1.27
Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med (2011) 1.23
The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res (2003) 1.19
Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J Virol (2005) 1.15
Novel genes and functional relationships in the adult mouse gastrointestinal tract identified by microarray analysis. Gastroenterology (2002) 1.15
Whatever happened to "neonatal hepatitis"? Clin Liver Dis (2006) 1.14
Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia. J Hepatol (2010) 1.14
Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest (2011) 1.13
Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology (2005) 1.13
IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One (2013) 1.09
Magnetic resonance elastography of the liver in patients status-post fontan procedure: feasibility and preliminary results. Congenit Heart Dis (2013) 1.08
MAPK signaling contributes to rotaviral-induced cholangiocyte injury and viral replication. Surgery (2007) 1.08
Cholangiocyte expression of alpha2beta1-integrin confers susceptibility to rotavirus-induced experimental biliary atresia. Am J Physiol Gastrointest Liver Physiol (2008) 1.07
Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05
Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology (2005) 1.04
Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg (2002) 1.04
The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice. J Virol (2011) 1.04
Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr Purif (2004) 1.03
Cholangiocyte secretion of chemokines in experimental biliary atresia. J Pediatr Surg (2009) 1.03
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr (2004) 1.01
Temporal-spatial activation of apoptosis and epithelial injury in murine experimental biliary atresia. Hepatology (2008) 1.01
Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics (2012) 1.00
Macrophages are targeted by rotavirus in experimental biliary atresia and induce neutrophil chemotaxis by Mip2/Cxcl2. Pediatr Res (2010) 1.00
Staging of biliary atresia at diagnosis by molecular profiling of the liver. Genome Med (2010) 0.99
Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine (2006) 0.98
Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine (2002) 0.98
IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein. Viral Immunol (2007) 0.97
Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl (2013) 0.96
Persistent rotavirus vaccine shedding in a new case of severe combined immunodeficiency: A reason to screen. J Allergy Clin Immunol (2010) 0.95
Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice. Gastroenterology (2006) 0.94
Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol (2006) 0.94
Evaluation of the child with suspected mitochondrial liver disease. J Pediatr Gastroenterol Nutr (2013) 0.93
Etiology and seasonality of viral respiratory infections in rural Honduran children. Pediatr Infect Dis J (2012) 0.93
Burden of rotavirus disease among children visiting pediatric emergency departments in Cincinnati, Ohio, and Oakland, California, in 1999-2000. Pediatrics (2008) 0.93
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant. Vaccine (2002) 0.92
Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr (2014) 0.92
Replication of a GWAS signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia. Hum Genet (2013) 0.92
Polyvalent complexes for vaccine development. Biomaterials (2013) 0.91
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor. BMC Gastroenterol (2006) 0.91
Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. Am J Physiol Gastrointest Liver Physiol (2002) 0.90
The SPLIT research agenda 2013. Pediatr Transplant (2013) 0.90
Evaluation of rotavirus dsRNA load in specimens and body fluids from experimentally infected juvenile macaques by real-time PCR. Virology (2005) 0.90
Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes. Vaccine (2003) 0.90
Rotarix: development of a live attenuated monovalent human rotavirus vaccine. Pediatr Ann (2006) 0.90
Estimating the rotavirus hospitalization disease burden and trends, using capture-recapture methods. Pediatr Infect Dis J (2010) 0.89
Logistic regression. Methods Mol Biol (2007) 0.89
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology (2006) 0.89
Cholestatic liver disease in children. Curr Gastroenterol Rep (2010) 0.89
Extrahepatic biliary atresia: current concepts and future directions. J Pediatr (Rio J) (2007) 0.88
Ductal plate malformation-like arrays in early explants after a Kasai procedure are independent of splenic malformation complex (heterotaxy). Pediatr Dev Pathol (2009) 0.88
Outcomes after liver transplantation: keep the end in mind. J Pediatr Gastroenterol Nutr (2006) 0.88
Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. J Biol Chem (2009) 0.88
Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule. J Pediatr Hematol Oncol (2014) 0.88
Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J (2005) 0.87
Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine (2007) 0.87
VP6: A candidate rotavirus vaccine. J Infect Dis (2010) 0.87
Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis (2012) 0.87
Discovery of a new strain of murine rotavirus that is consistently shed in large quantities after oral inoculation of adult mice. Virology (2004) 0.87
Nonmedical costs associated with rotavirus disease requiring hospitalization. Pediatr Infect Dis J (2005) 0.86
Biliary atresia and Th1 function: linking lymphocytes and bile ducts: commentary on the article by Mack et al. on page 79. Pediatr Res (2004) 0.86
Rotavirus infection of human cholangiocytes parallels the murine model of biliary atresia. J Surg Res (2012) 0.86
Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study. Can J Infect Dis Med Microbiol (2008) 0.86
Hepatic to pancreatic switch defines a role for hemostatic factors in cellular plasticity in mice. Proc Natl Acad Sci U S A (2005) 0.85